(Q33948617)

30 July 2017

1 reference

title

Diagnostic criteria and classification of mastocytosis: a consensus proposal (English)

1 reference

30 July 2017

17

Metcalfe DD

1 reference

30 July 2017

Valent P

1

1 reference

30 July 2017

Horny HP

2

1 reference

30 July 2017

Escribano L

3

1 reference

30 July 2017

Longley BJ

4

1 reference

30 July 2017

Li CY

5

1 reference

30 July 2017

Schwartz LB

6

1 reference

30 July 2017

Marone G

7

1 reference

30 July 2017

Nuñez R

8

1 reference

30 July 2017

Akin C

9

1 reference

30 July 2017

Sotlar K

10

1 reference

30 July 2017

Sperr WR

11

1 reference

30 July 2017

Wolff K

12

1 reference

30 July 2017

Brunning RD

13

1 reference

30 July 2017

Parwaresch RM

14

1 reference

30 July 2017

Austen KF

15

1 reference

30 July 2017

Lennert K

16

1 reference

30 July 2017

Vardiman JW

18

1 reference

30 July 2017

Bennett JM

19

1 reference

30 July 2017

publication date

1 July 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

25

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

603-625

1 reference

Mast cells and mast cell neoplasia: a review

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Tissue mast cells in health and disease.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Significance of systemic mast cell disease with associated hematologic disorders

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mast cell leukemia: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-M1

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Classification and diagnosis of mastocytosis: current status

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A proposed classification of mastocytosis incorporating molecular genetics

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

[Shock and coagulation disorders in systemic mastocytosis]

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Hyperchlorhydria and Hyperhistaminemia in a Patient with Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Gastrointestinal dysfunction in systemic mastocytosis. A prospective study.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Gastrointestinal abnormalities and involvement in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Heparin Activity in Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Clinical and histopathological aspects of cutaneous mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A fatal case of portal hypertension complicating systemic mastocytosis in an adolescent

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Variceal bleeding, hypersplenism, and systemic mastocytosis. Pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Radiological features of systemic mast-cell disease

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis: CT and US features of abdominal manifestations

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Bone marrow findings in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis. Extracutaneous manifestations.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Lymph node findings in generalized mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Spleen findings in generalized mastocytosis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Liver findings in generalized mastocytosis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

The liver, spleen, and lymph nodes in mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Different patterns of spleen involvement in systemic and malignant mastocytosis. A histological and immunohistochemical study of three cases

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Interstitial Cystitis and Bladder Mastocytosis in a Woman with Chronic Urticaria

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Urticaria Pigmentosa:A Clinical, Hematopathologic, and Serologic Study of 30 Adults

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Bone marrow findings in adult patients with urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mast cell disease: a clinical and hematopathologic study of 26 cases

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Diagnostic value of immunostaining for tryptase in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Immunoreactivity of normal and neoplastic human tissue mast cells

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Use of monoclonal antibody KP1 for identifying normal and neoplastic human mast cells

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Concomitant bone changes in urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

The potential clinical utility of serum alpha-protryptase levels

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mast cell lineage development and phenotypic regulation

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

c-kit mutation in a population of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

C-kit mutations and mast cell disorders. A model of activating mutations of growth factor receptors

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A new c-kit mutation in a case of aggressive mast cell disease

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

1995 Mack-Forster Award Lecture. Review. Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mast cell leukaemia: evidence for bone marrow origin of the pathological clone

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Concurrent acute myeloid leukemia and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Primary thrombocythaemia associated with systemic mastocytosis: a report of five cases

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Acute nonlymphocytic leukemia in systemic mastocytosis with biclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Generalized cutaneous mastocytosis and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Lymphadenopathic mastocytosis with eosinophilia and biclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mast cell disease followed by leukemia with clonal evolution.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mast cell disease associated with hairy cell leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A case of bone marrow mastocytosis associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mastocytosis: molecular mechanisms and clinical disease heterogeneity.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Telangiectasia macularis eruptiva perstans

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mast cells in cutaneous mastocytosis: accumulation of the MCTC type

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Two types of human mast cells that have distinct neutral protease compositions

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Diffuse cutaneous mastocytosis with multiple cutaneous mastocytomas. Report of a case with clinical, histopathological and ultrastructural aspects

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Systemic mastocytosis with extensive large cutaneous mastocytomas: surgical management

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Solitary mastocytoma of the eyelid. A case report with special reference to the immunocytology of human tissue mast cells, and a review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Benign and malignant mast cell proliferations: Diagnosis and separation using a pH-dependent toluidine blue stain in tissue section

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Human bone marrow mast cells in systemic mast cell disease. Ultrastructure and evaluation of fixation and staining techniques

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Cytobiological and clinical aspects of tissue mast cell leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Malignant mastocytosis with circulating mast cells

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Mast cell sarcoma of the larynx

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

SOLITARY MAST CELL GRANULOMA (HISTIOCYTOMA) OF THE LUNG; A HISTOPATHOLOGIC, TISSUE CULTURE AND TIME-LAPSE CINEMATOGRAPHIC STUDY

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Solitary mast cell tumor of the lung.

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A solitary manifestation of mastocytosis in the head and neck

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

The treatment of mastocytosis: an overview

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Treatment of mastocytosis: pharmacologic basis and current concepts

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Intervention with epinephrine in hypotension associated with mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

A case of systemic mastocytosis; therapeutic efficacy of ketotifen

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Cromolyn sodium in the management of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Oral disodium cromoglycate in the treatment of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Short- and Long-Term Effectiveness of Oral and Bath PUVA Therapy in Urticaria pigmentosa and Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Response to interferon alfa-2b in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Response of severe systemic mastocytosis to interferon alpha

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Long-term response to interferon-alpha in a patient with systemic mastocytosis and chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Treatment of three patients with systemic mastocytosis with interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016/S0145-2126(01)50038-8

7 January 2021

10.1016/S0145-2126(01)00038-8

Identifiers

DOI

1 reference

30 July 2017

1 reference